The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Type 1 diabetes (T1D) results from progressive loss of pancreatic islet mass through autoimmunity targeted at a diverse, yet limited, series of molecules that are expressed in the pancreatic β cell. Identification of these molecular targets provides insight into the pathogenic process, diagnostic assays, and potential therapeutic agents. Autoantigen candidates were identified from microarray expression profiling of human and rodent pancreas and islet cells and screened with radioimmunoprecipitation assays using new-onset T1D and prediabetic sera. A high-ranking candidate, the zinc transporter ZnT8 (Slc30A8), was targeted by autoantibodies in 60–80% of new-onset T1D compared with <2% of controls and <3% type 2 diabetic and in up to 30% of patients with other autoimmune disorders with a T1D association. ZnT8 antibodies (ZnTA) were found in 26% of T1D subjects classified as autoantibody-negative on the basis of existing markers [glutamate decarboxylase (GADA), protein tyrosine phosphatase IA2 (IA2A), antibodies to insulin (IAA), and islet cytoplasmic autoantibodies (ICA)]. Individuals followed from birth to T1D showed ZnT8A as early as 2 years of age and increasing levels and prevalence persisting to disease onset. ZnT8A generally emerged later than GADA and IAA in prediabetes, although not in a strict order. The combined measurement of ZnT8A, GADA, IA2A, and IAA raised autoimmunity detection rates to 98% at disease onset, a level that approaches that needed to detect prediabetes in a general pediatric population. The combination of bioinformatics and molecular engineering used here will potentially generate other diabetes autoimmunity markers and is also broadly applicable to other autoimmune disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Islet cell autoantibodies comprise autoantibodies to islet cell cytoplasm (ICA), to native insulin [referred to as “insulin autoantibodies” (IAA) ( 286 and IA-2bA (also known as phogrin) (291)], and to three variants of zinc transporter 8 (ZnT8A) (292,293).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [292]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pancreatic autoantibodies, low levels of C-peptide and insulin requirement at the time of diagnosis are all suggestive of T1DM66,67.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [67]
Experimental — accuracy not yet measuredIn the citing paper
“The presence of multiple islet cell autoantibodies (IAA, GAD65A, IA-2A/IA-2bA, or ZnT8A) is associated with a .90%risk of type 1 diabetes (292,295,296);”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [292]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Baekkeskov, S., Aanstoot, H.-J., Christgai, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, H., & Camilli, P.-D. (1990) · Nature · doi:10.1038/347151a0 · Cited by 1,964
Large-scale analysis of the human and mouse transcriptomes
Su, A. I., Cooke, M. P., Ching, K. A., Hakak, Y., Walker, J. R., Wiltshire, T., Orth, A. P., Vega, R. G., Sapinoso, L. M., Moqrich, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012025199 · Cited by 1,466
THE NOD MOUSE: A Model of Immune Dysregulation
Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115643 · Cited by 1,113
Insulin antibodies in insulin-dependent diabetics before insulin treatment
Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K., & Paquette, T. L. (1983) · Science · doi:10.1126/science.6362005 · Cited by 1,078
Verge, C. F., Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M., Chase, H. P., Eisenbarth, G. S., & Jackson, R. A. (1996) · Diabetes · doi:10.2337/diab.45.7.926 · Cited by 827
Self-citationChimienti, F., Devergnas, S., Favier, A., & Seve, M. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2330 · Cited by 470
Promoter features related to tissue specificity as measured by Shannon entropy
Schug, J., Schuller, W.-P., Kappen, C., Salbaum, J. M., Bucan, M., & Stoeckert, C. J. (2005) · Genome Biology · doi:10.1186/gb-2005-6-4-r33 · Cited by 447
Bingley, P. J., Christie, M. R., Bonifacio, E., Bonfanti, R., Shattock, M., Fonte, M.-T., Bottazzo, G.-F., & Gale, E. A. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1304 · Cited by 389
Lieberman, S. M., Evans, A. M., Han, B., Takaki, T., Vinnitskaya, Y., Caldwell, J. A., Serreze, D. V., Shabanowitz, J., Hunt, D. F., Nathenson, S. G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932778100 · Cited by 388
Diabetes Antibody Standardization Program: first assay proficiency evaluation
Bingley, P. J., Bonifacio, E., Mueller, P. W., & Laboratories, P. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1128 · Cited by 362
Pihoker, C., Gilliam, L. K., Hampe, C. S., & Lernmark, A. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s52 · Cited by 303
Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?
Trudeau, J. D., Dutz, J. P., Arany, E., Hill, D. J., Fieldus, W. E., & Finegood, D. T. (2000) · Diabetes · doi:10.2337/diabetes.49.1.1 · Cited by 290
Kambe, T., Narita, H., Yamaguchi-Iwai, Y., Hirose, J., Amano, T., Sugiura, N., Sasaki, R., Mori, K., Iwanaga, T., & Nagao, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200910200 · Cited by 254
Development of Type 1 Diabetes despite Severe Hereditary B-Cell Deficiency
Martin, S., Wolf-Eichbaum, D., Duinkerken, G., Scherbaum, W. A., Kolb, H., Noordzij, J. G., & Roep, B. O. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010465 · Cited by 254
Bao, F., Yu, L., Babu, S., Wang, T., Hoffenberg, E. J., Rewers, M., & Eisenbarth, G. S. (1999) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0303 · Cited by 241
Self-citationBonifacio, E., Lampasona, V, Genovese, S., Ferrari, M., & Bosi, E. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.11.5419 · Cited by 239
Pietropaolo, M., Castaño, L., Babu, S., Buelow, R., Kuo, Y. L., Martin, S., Martin, A., Powers, A. C., Prochazka, M., & Naggert, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116574 · Cited by 231
A comprehensive guide to antibody and T‐cell responses in type 1 diabetes
Lieberman, S. M., & DiLorenzo, T. P. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00152.x · Cited by 171
CASTAÑO, L., RUSSO, E., ZHOU, L., LIPES, M. A., & EISENBARTH, G. S. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1197 · Cited by 156
Self-citationVerge, C. F., Gianani, R., Kawasaki, E., Yu, L., Pietropaolo, M., Chase, P., & Eisenbarth, G. S. (1996) · Journal of Autoimmunity · doi:10.1006/jaut.1996.0051 · Cited by 152
Self-citationNg, B., Yang, F., Huston, D. P., Yan, Y., Yang, Y., Xiong, Z., Peterson, L. E., Wang, H., & Yang, X.-F. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.09.006 · Cited by 131
Cloning and Expression of IDDM-Specific Human Autoantigens
Rabin, D. U., Pleasic, S. M., Palmer-Crocker, R., & Shapiro, J. A. (1992) · Diabetes · doi:10.2337/diab.41.2.183 · Cited by 124
Wang, J., Miao, D., Babu, S., Yu, J., Barker, J., Klingensmith, G., Rewers, M., Eisenbarth, G. S., & Yu, L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1494 · Cited by 113
Self-citationRewers, M., Norris, J. M., Eisenbarth, G. S., Erlich, H. A., Beaty, B. L., KLINGENSMITH, G. J., Hoffman, M., Yu, L., Bugawan, T. L., Blair, A., et al. (1996) · Journal of Autoimmunity · doi:10.1006/jaut.1996.0055 · Cited by 111
Self-citationArden, S. D., Zahn, T., Steegers, S., Webb, S., Bergman, B., O'Brien, R. M., & Hutton, J. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.531 · Cited by 111
Self-citationArden, S. D., Roep, B. O., Neophytou, P. I., Usac, E. F., Duinkerken, G., de Vries, R. R., & Hutton, J. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118448 · Cited by 85
Self-citationBarker, J. M., Ide, A., Hostetler, C., Yu, L., Miao, D., Fain, P. R., Eisenbarth, G. S., & Gottlieb, P. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0874 · Cited by 83
Self-citationSchatz, D., & Bingley, P. J. (2001) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2001.14.s1.619 · Cited by 78
Hawkes, C. J., Wasmeier, C., Christie, M. R., & Hutton, J. C. (1996) · Diabetes · doi:10.2337/diab.45.9.1187 · Cited by 76
Self-citationPietropaolo, M., Peakman, M., Pietropaolo, S. L., Zanone, M. M., Foley, T. P., BECKER, D. J., & Trucco, M. (1998) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0170 · Cited by 72
Boîtard, C., Villà, M. C., Bécourt, C., Gia, H. P., Huc, C., Sempé, P., Portier, M., & Bach, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.172 · Cited by 55
Achenbach, P., Warncke, K., Reiter, J., Williams, A. J. K., Ziegler, A., Bingley, P. J., & Bonifacio, E. E. (2006) · Diabetologia · doi:10.1007/s00125-006-0451-9 · Cited by 51
Type 1 diabetes alters anti-hsp90 autoantibody isotype
Qin, H.-Y., Mahon, J. L., Atkinson, M. A., Chaturvedi, P., Lee‐Chan, E., & Singh, B. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00035-0 · Cited by 51
RegII Is a β-Cell Protein and Autoantigen in Diabetes of NOD Mice
Gürr, W., Shaw, M., Li, Y., & Sherwin, R. (2006) · Diabetes · doi:10.2337/db06-0669 · Cited by 51
Hermann, R., Bartsocas, C. S., Soltész, G., Vazeou, A., Paschou, P., Bozas, E., Malamitsi‐Puchner, A., Simell, O., Knip, M., & Ilonen, J. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.455 · Cited by 50
Clifford, K. S., & MacDonald, M. J. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00141-8 · Cited by 45
Humoral autoreactivity to an alternatively spliced variant of ICA512/IA-2 in Type I diabetes
Park, Y. S., Kawasaki, E., Kelemen, K., Yu, L., Schiller, M. R., Rewers, M., Mizuta, M., Eisenbarth, G. S., & Hutton, J. C. (2000) · Diabetologia · doi:10.1007/s001250051525 · Cited by 34
Self-citationAutoantibodies Against Gad65Rather Than Gad67Precede the Onset of Type 1 Diabetes
Lühder, F., Schlosser, M., Mauch, L., Haubruck, H., Rjasanowski, I. M., Michaelis, D., Kohnert, K., & ZIEGLER, M. (1994) · Autoimmunity · doi:10.3109/08916939409009534 · Cited by 33
Autoantibodies to Islet Amyloid Polypeptide in Diabetes
Clark, A., Yon, S., de Koning, E. J. P., & Holman, R. R. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01675.x · Cited by 22
CD3-Specific Antibodies as Promising Tools to Aim at Immune Tolerance in the Clinic
Chatenoud, L. (2006) · International Reviews of Immunology · doi:10.1080/08830180600743032 · Cited by 20
Invasion of the killer B's in type 1 diabetes
Pablo, A. S. (2006) · Frontiers in bioscience · doi:10.2741/2221 · Cited by 11
GeneSpeed: protein domain organization of the transcriptome
Kutchma, A. J., Quayum, N., & Jensen, J. N. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl990 · Cited by 11
Self-citationBergerot, I., Souchier, C., & Thivolet, C. H. (1993) · PubMed · Cited by 5
Research works printed but not linked: 1
- I Bergerot, C Souchier, C Thivolet Can R Acad Sci III 316, 1368–1373 (1993).
Cited by
(2) Classification and diagnosis of diabetes
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s005 · Cited by 1,841
Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012
Mayer-Davis, E. J., Lawrence, J. M., Dabelea, D., Divers, J., Isom, S., Dolan, L., Imperatore, G., Linder, B., Marcovina, S., Pettitt, D. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610187 · Cited by 1,476
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
Kambe, T., Tsuji, T., Hashimoto, A., & Itsumura, N. (2015) · Physiological Reviews · doi:10.1152/physrev.00035.2014 · Cited by 1,158
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
Metadata
- Authors
- Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., & Hutton, J. C.
- Affiliations
- University of Colorado Denver (US)
- Harvard University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-10-23
- Volume
- 104
- Issue
- 43
- Pages
- 17040-17045
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2040407
- OpenAlex
- W1993312496
- Cited by
- 1,014
- References
- 44
- Citations by year
- 2026: 22 · 2025: 28 · 2024: 30 · 2023: 40 · 2022: 44 · 2021: 37 · 2020: 53 · 2019: 51 · 2018: 32 · 2017: 52 · 2016: 65 · 2015: 69 · 2014: 72 · 2013: 77 · 2012: 87
- FWCI
- 32.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK57516)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057516, U19DK061248)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 1 diabetes, zinc transporter 8, SLC30A8, zinc transporters, autoantigens, autoantibodies, autoimmunity, pancreatic beta cells, islet autoimmunity, GADA, islet autoantibodies, prediabetes, autoimmunity markers, disease onset
- MeSH terms
- Zinc Transporter 8, Adolescent, Adult, Aged, Antibody Specificity, Epitopes, Autoantibodies, Autoantigens, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Humans, Infant, Male, Middle Aged, Organ Specificity, Risk Factors, Autoimmunity, Age of Onset, Age Distribution, Oligonucleotide Array Sequence Analysis, Cation Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.